期刊文献+

脐静脉内皮细胞的提取与形态学观察 被引量:2

The isolation and morphology observation of umbilical vein endothelia cells
下载PDF
导出
摘要 目的获取胶原酶灌注法提取脐静脉内皮细胞的有效方法。探讨内皮细胞培养过程中生长因子的添加浓度,并对内皮细胞进行形态学观察及鉴定。方法采用血球计数法对在不同时间和不同胶原酶浓度下提取的脐静脉内皮细胞进行计数。同时采用MTT法探讨了生长因子(Endothelia Cells Growth Supplement,ECGS)的浓度对脐静脉内皮细胞生长的作用,并用倒置显微镜和HE染色法观察了脐静脉内皮细胞的形态,Ⅷ因子免疫组化对获取的脐静脉内皮细胞进行鉴定。结果当提取时间为10~30min时,随着时间的增加,内皮细胞的提取数量增加;当胶原酶的浓度为0.1%~0.3%时,消化的脐静脉内皮细胞数量逐渐增加。ECGS的浓度为30μg/mL时,促进脐静脉内皮细胞的生长,种植4天后细胞进入平台期。脐静脉内皮细胞体外培养形态为“铺路石”状。Ⅷ因子免疫组化鉴定为阳性。结论胶原酶灌注法是一种快速而有效的获取血管内皮细胞的方法,可以为组织工程血管内皮化提供充足的种子细胞。 Aim To obtain effective method for isolated umbilical vein endothelia cells (UVECS) by collagenase infusion and investigate optimum concentration of growth factor. Methods The UVECS, isolated with different incubating time and collagenase concentration, were counted by blood counting chamber. The effect of growth factor ECGS( endothelia ceils growth supplement) on UVECS was investigated by MTT analysis. The morphology of UVECS was observed using phase-contrast microscope and HE, and UVECS were characterized by immunochemistry with the use of an anti Ⅷ factor antibody. Results The number of UVECS increased with incubation time being longer (10 -30 min) ; The isolated UVECS were much more in correspondence with collagenase concentration increasing(0. 1% -0. 3% ). The growth rate of UVECS was improved greatly when the concentration of ECGS being 30μg/ml, and the UVECS were in plateau phase after being implanted 4 days. The morphology of UVECS was slabstone-like and the identification of UVECS showed positive. Conclusion Collagenase infusion is an effective method for obtaining vascular endothelia cells,which could provide enough seed cells for vascular engineering.
出处 《西北大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第5期809-813,共5页 Journal of Northwest University(Natural Science Edition)
基金 国家自然科学基金资助项目(20776119) 西安市科技计划基金资助项目(YF07078) 陕西省教育厅专项科研计划基金资助项目(08JK452)
关键词 脐静脉内皮细胞 免疫组化 胶原酶灌注法 Umbilical vein endothelia ceils immunochemistry collagenase infusion
  • 相关文献

参考文献5

  • 1HUGHES S E. Functional Characterization of the Spontaneously Transformed Human Umbilical Vein Endothelial Cell Line ECV304 : Use in an in Vitro Model of Angiogenesis [ J ]. Experimental Cell Research, 1996, 225 : 171- 185.
  • 2FEUGIER P, BLACKB R A, HUNT J A, et al. Attachment, morphology and adherence of human endothelial cells to vascular prosthesis materials under the action of shear stress [ J ]. Biomaterial, 2005,26 : 1 457-1 466.
  • 3冯怡,马清钧.人脐静脉血管内皮细胞的分离、培养、鉴定及试验研究[J].生物技术通讯,2002,13(2):138-140. 被引量:7
  • 4RICHARD L, VELASCO P, DETMAR M. A Simple Immunomagnetic Protocol for the Selective Isolation and Long-Term Culture of Human Dermal Microvascular Endothelial Cells [J]. Experimental Cell Research, 1998, 240:1-6.
  • 5王德伟,范代娣,费强.BHK-21细胞在生物材料溶液中黏附及增殖比较[J].西北大学学报(自然科学版),2007,37(4):603-606. 被引量:1

二级参考文献10

共引文献6

同被引文献13

  • 1Wang A,Rana S,Karumanchi SA.Preeclampsia:the role of angiogenic factors in its pathogenesis[J].Physiology(Bethesda),2009,24(6):147-158.
  • 2Fromowitz FB,Viola MV,Chao S,et al.ras p21 expression in the progression of breast cancer[J].Hum Pathol,1987,18(12):1268-1275.
  • 3Matsubara K,Higaki T,Matsubara Y,et al.Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia[J].Int J Mol Sci,2015,16(3):4600-4614.
  • 4Johal T,Lees CC,Everett TR,et al.The nitric oxide pathway and possible therapeutic options in pre-eclampsia[J].Br J Clin Pharmacol,2014,78(2):244-257.
  • 5Scatena R,Bottoni P,Pontoglio A,et al.Pharmacological modulation of nitric oxide release:new pharmacological perspectives,potential benefits and risks[J].Curr Med Chem,2010,17(1):61-73.
  • 6Zawiejska A,Wender-Ozegowska E,Iciek R,et al.Concentrations of endothelial nitric oxide synthase,angiotensin-converting enzyme,vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders[J].J Hum Hypertens,2014,28(11):670-676.
  • 7Laskowska M,Laskowska K,Terbosh M,et al.A comparison of maternal serum levels of endothelial nitric oxide synthase,asymmetric dimethylarginine,and homocysteine in normal and preeclamptic pregnancies[J].Med Sci Monit,2013,19(5):430-437.
  • 8Savvidis A,Daniilidis A,Giannoulis C,et al.Correlation between asymmetric dimethylarginine maternal plasma levels and preeclampsia[J].Clin Exp Obstet Gynecol,2011,38(2):134-136.
  • 9Masoura S,Kalogiannidis IA,Gitas G,et al.Biomarkers in preeclampsia:a novel approach to early detection of the disease[J].J Obstet Gynaecol,2012,32(7):609-616.
  • 10Alacam H,Dikmen ZG,Yaman H,et al.The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia[J].Fetal Pediatr Pathol,2011,30(6):387-393.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部